Haemonetics Corp (HAE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 03-2020 | 03-2019 | 03-2018 | 03-2017 | 03-2016 | |
| Sales | 988,479 | 967,579 | 903,923 | 886,116 | 908,832 |
| Cost of Goods | 503,966 | 550,043 | 492,015 | 507,622 | 502,918 |
| Gross Profit | 484,513 | 417,536 | 411,908 | 378,494 | 405,914 |
| Operating Expenses | 382,128 | 334,034 | 355,766 | 398,497 | 450,774 |
| Operating Income | 103,351 | 83,545 | 56,157 | -19,381 | -43,942 |
| Interest Expense | 16,199 | 9,912 | 4,525 | 8,095 | 9,474 |
| Other Income | 0 | 0 | 8,000 | 0 | 0 |
| Pre-tax Income | 87,152 | 73,633 | 59,632 | -27,476 | -53,416 |
| Income Tax | 10,626 | 18,614 | 14,060 | -1,208 | 2,163 |
| Net Income Continuous | 76,526 | 55,019 | 45,572 | -26,268 | -55,579 |
| Net Income | $76,526 | $55,019 | $45,572 | $-26,268 | $-55,579 |
| EPS Basic Total Ops | 1.51 | 1.07 | 0.86 | -0.51 | -1.09 |
| EPS Basic Continuous Ops | 1.51 | 1.07 | 0.86 | -0.51 | -1.09 |
| EPS Diluted Total Ops | 1.48 | 1.04 | 0.85 | -0.51 | -1.09 |
| EPS Diluted Continuous Ops | 1.48 | 1.04 | 0.85 | -0.51 | -1.09 |
| EPS Diluted Before Non-Recurring Items | 3.31 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $214,236 | $192,963 | $145,404 | $70,352 | $45,969 |